![Nathalie Dubois-Stringfellow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 23 998 $ as of 31/07/2026
Nathalie Dubois-Stringfellow has held roles at XOMA (US) LLC as Senior Director- Alliance Management and at Sangamo Therapeutics, Inc. as Chief Development Officer.
Both positions are current.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 25/05/2026 | 328,733 ( 0.08% ) | 23 998 $ | 31/07/2026 |
| Companies | Position | Start |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2019 |
XOMA (US) LLC
 XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 2 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
